Retatrutide Shows Positive Results in Phase 3 Obesity Trials | Retatrutide News

Retatrutide has shown significant improvements in weight and A1C in two Phase 3 obesity trials. This highlights its potential in the treatment of obesity.
Clinical Trials · October 17, 2026